Focus on the R&D, production and sales of complex APIs and preparations, and CRO/CDMO of oligonucleotide drugs
Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide
We will be participating in the CPHI exhibition in Barcelona, Spain from October 24 to October 26, 2023. Welcome to our booth 6A10 in Hall 6.0.
Academician Cheng Jinpei, a famous organic chemist and professor of Tsinghua University and Nankai University, visited Yangzhou Aurisco Pharmaceutical Co., Ltd..
Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).
3
Manufacturing Facilities6
R & D Centers240+
Scientists400+
Partnerships1400+
Staff membersWe will be participating in the CPHI exhibition in Barcelona, Spain from October 24 to October 26, 2023. Welcome to our booth 6A10 in Hall 6.0.
Academician Cheng Jinpei, a famous organic chemist and professor of Tsinghua University and Nankai University, visited Yangzhou Aurisco Pharmaceutical Co., Ltd..
Yangzhou, China, August 11th, 2023 – Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA).
Aurisco will attend CPHI Korea, 30 August - 1 September 2023, COEX, Seoul, Korea. #booth at L-35 #
Sirnaomics and Aurisco jointly explore opportunities and pathways to overcome challenges in the development and manufacturing of oligonucleotides, aiming to strengthening cooperation to accelerate the global launch of new oligonucleotides drugs.
Aurisco Pharmaceutical’s Oral Dydrogesterone Tablets Get Marketing Authorization Approval in China Under The Brand Name AUXITON.
Aurisco will Exhibit at CPHI South East Asia 12-14 July 2023 ，Queen Sirikit NationaConvention CenterBangkok, Thailand. Stand at #D70#
Aurisco will Exhibit at CPHI China 19-21 June 2023. Shanghai New International Expo Center. #booth at W2C02 #
Aurisco will attend TIDES USA 2023 7 - 10 May 2023 San Diego, CA, USA
Aurisco will participate in RDD Europe 2023 in Nice, France
Aurisco will attend CPHI Japan, April 19th to 21st, 2023,Tokyo, Japan. #booth at 5N-16 #
Aurisco will attend DCAT Week 2023 20-23 March 2023. New York, USA
Aurisco will attend RNA Leaders, March 15-16, 2023, Basel Switzerland.
This year Aurisco turns 25 years old. Aurisco’s founder and chairman, Peng Zhien reflects on the company’s 25th anniversary, how it all started, the contribution of the business and what lies ahead.
Aurisco will attend TIDES Asia, March 3rd to 7th, 2023, Kyoto, Japan.
January 3,2023，Aurisco to build an Oligonucleotide FlexFactory™ for commercial cGMP production in cooperation with Cytiva.
Aurisco will attend the 41st J.P. Morgan Healthcare Conference 9-12 Jan 2023 San Francisco,CA,USA
Aurisco will participate in DDL 2022 in Edinburgh, UK, from December 7 to 9, 2022. Edinburgh International Conference Centre.
Aurisco will attend TIDES Europe 16 - 18 November 2022. Austria Center Vienna.
Aurisco is glad to announce our participance in CPHI Europe from Nov 1 to Nov 3. 2022. Aurisco 's entire team including our BD from US, EU is looking forward to meet our partners and friends , to present our new products , pipeline and CDMO service . Pls visit us at our booth (110H20, in hall no 11
We are going to attend DCAT week in New York City on March 21-24, 2022, let's meet soon ! Our meeting room location : Benjamin Hotel .
Shanghai Aurisco Biotechnology Co., Ltd. was Established
On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.
We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.
We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12
We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.
We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11, 2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.
On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37 yuan, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.
We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.
We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12
We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.
We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11, 2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.
Follow Aoruite WeChat official account
